10 Jul 2024
- February 2023: The Clinical Study on the Analgesic Activity of PAX-1 in Patients with Persistent Cancer Pain was approved by the DNM and CNEIS in El Salvador.
- July 2021: Sodium meta-arsenite received orphan-drug designation from the US FDA for the “treatment of patients with glioblastoma (GBM).”